1. Home
  2. RDHL vs OMEX Comparison

RDHL vs OMEX Comparison

Compare RDHL & OMEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • OMEX
  • Stock Information
  • Founded
  • RDHL 2009
  • OMEX 1986
  • Country
  • RDHL Israel
  • OMEX United States
  • Employees
  • RDHL N/A
  • OMEX N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • OMEX Marine Transportation
  • Sector
  • RDHL Health Care
  • OMEX Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • OMEX Nasdaq
  • Market Cap
  • RDHL 11.2M
  • OMEX 10.2M
  • IPO Year
  • RDHL N/A
  • OMEX N/A
  • Fundamental
  • Price
  • RDHL $7.15
  • OMEX $0.39
  • Analyst Decision
  • RDHL
  • OMEX
  • Analyst Count
  • RDHL 0
  • OMEX 0
  • Target Price
  • RDHL N/A
  • OMEX N/A
  • AVG Volume (30 Days)
  • RDHL 14.3K
  • OMEX 491.1K
  • Earning Date
  • RDHL 11-19-2024
  • OMEX 11-13-2024
  • Dividend Yield
  • RDHL N/A
  • OMEX N/A
  • EPS Growth
  • RDHL N/A
  • OMEX N/A
  • EPS
  • RDHL N/A
  • OMEX 0.61
  • Revenue
  • RDHL $3,707,000.00
  • OMEX $799,139.00
  • Revenue This Year
  • RDHL $224.90
  • OMEX N/A
  • Revenue Next Year
  • RDHL $82.69
  • OMEX N/A
  • P/E Ratio
  • RDHL N/A
  • OMEX $0.73
  • Revenue Growth
  • RDHL N/A
  • OMEX N/A
  • 52 Week Low
  • RDHL $6.80
  • OMEX $0.40
  • 52 Week High
  • RDHL $82.00
  • OMEX $5.57
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 29.71
  • OMEX 26.71
  • Support Level
  • RDHL $7.98
  • OMEX $0.40
  • Resistance Level
  • RDHL $7.36
  • OMEX $0.54
  • Average True Range (ATR)
  • RDHL 0.37
  • OMEX 0.04
  • MACD
  • RDHL -0.12
  • OMEX 0.05
  • Stochastic Oscillator
  • RDHL 0.00
  • OMEX 6.31

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About OMEX Odyssey Marine Exploration Inc.

Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodule (battery metals) projects. Its projects include ExO Phosphate project, CIC, Ocean Minerals, and LIHIR Gold project.

Share on Social Networks: